Cerebras Systems CBRS NASDAQ · Technology · United States
$101.08 +7.92% +$7.42
Summary
42 / 100 · Bulios Score
What speaks for it
- Out of every 100 USD of revenue, 47 USD is left as net profit.
- Revenue grew by 175% a year over the last 3 years.
- It holds more cash than debt: $7.43B against $1.49B.
- Analysts expect revenue to grow by 74% this fiscal year.
What to watch
- The share price is above the Bulios Fair Price.
- It reports a profit, yet spends more cash than it brings in.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBy our assumptions the business is worth less than its shares cost today.
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 89.2 USD for 1 USD of yearly profit.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 175% a year over the last 3 years. For the next fiscal year analysts expect revenue to grow by 74%.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $512.4M.
Profitability in detailIs it financially healthy?
YesIt holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 9
- Hold 0
- Sell 0
Today's price within the analysts' price targets
The average target of $300.5 is 197% above today's price. 100% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.